Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Effectiveness of opiate substitution treatment in reducing HIV risk behaviors among African, Caribbean and black people: a systematic review protocol.

Nguemo Djiometio JB, Mohamud H, Njoroge I, Nelson LE, Kahan M.

JBI Database System Rev Implement Rep. 2019 Oct 12. doi: 10.11124/JBISRIR-D-19-00112. [Epub ahead of print]

PMID:
31634212
2.

Opioid agonist therapy during residential treatment of opioid use disorder: Cohort study on access and outcomes.

Spithoff S, Meaney C, Urbanoski K, Harrington K, Que B, Kahan M, Leece P, Shehadeh V, Sullivan F.

Can Fam Physician. 2019 Oct;65(10):e443-e452.

3.
4.

Canada's hidden opioid crisis: the health care system's inability to manage high-dose opioid patients: Fallout from the 2017 Canadian opioid guidelines.

Clarke H, Bao J, Weinrib A, Dubin RE, Kahan M.

Can Fam Physician. 2019 Sep;65(9):612-614. No abstract available.

5.

Substance use disorders among African, Caribbean and Black (ACB) people in Canada: a scoping review protocol.

Nguemo JD, Iroanyah N, Husbands W, Nelson LE, Maina G, Njoroge I, Owino M, Kahan M, Miller D, Wong J.

BMJ Open. 2019 Jul 10;9(7):e028985. doi: 10.1136/bmjopen-2019-028985.

6.
7.

Quality of primary care among individuals receiving treatment for opioid use disorder.

Spithoff S, Kiran T, Khuu W, Kahan M, Guan Q, Tadrous M, Leece P, Martins D, Gomes T.

Can Fam Physician. 2019 May;65(5):343-351.

8.

Buprenorphine unobserved "home" induction: a survey of Ontario's addiction physicians.

Srivastava A, Kahan M, Leece P, McAndrew A.

Addict Sci Clin Pract. 2019 May 1;14(1):18. doi: 10.1186/s13722-019-0146-4.

9.

Long-term factor structure of the Rivermead Post-Concussion Symptom Questionnaire in mild traumatic brain injury and normative sample.

Barker-Collo S, Theadom A, Starkey NJ, Kahan M, Jones K, Feigin V.

Brain Inj. 2019;33(5):618-622. doi: 10.1080/02699052.2019.1570339. Epub 2019 Jan 30.

PMID:
30700169
10.

Depression and anxiety across the first 4 years after mild traumatic brain injury: findings from a community-based study.

Barker-Collo S, Theadom A, Jones K, Starkey N, Kahan M, Feigin V.

Brain Inj. 2018;32(13-14):1651-1658. doi: 10.1080/02699052.2018.1540797. Epub 2018 Oct 29.

PMID:
30373399
11.

The 2017 Canadian opioid guideline: already time for an overhaul.

Kahan M, Dubin R, Clarke H.

CMAJ. 2018 Mar 12;190(10):E300. doi: 10.1503/cmaj.68662. No abstract available.

12.

Opioid use in pregnancy and parenting: An Indigenous-based, collaborative framework for Northwestern Ontario.

Jumah NA, Bishop L, Franklyn M, Gordon J, Kelly L, Mamakwa S, O'Driscoll T, Olibris B, Olsen C, Paavola N, Pilatzke S, Small B, Kahan M.

Can J Public Health. 2018 Jan 22;108(5-6):e616-e620. doi: 10.17269/cjph.108.5524.

PMID:
29356671
13.

Factor structure of the Rivermead Post-Concussion Symptoms Questionnaire over the first year following mild traumatic brain injury.

Barker-Collo S, Theadom A, Starkey N, Kahan M, Jones K, Feigin V.

Brain Inj. 2018;32(4):453-458. doi: 10.1080/02699052.2018.1429659. Epub 2018 Jan 22.

PMID:
29355392
14.

Incidence of spinal epidural lipomatosis in patients with spinal stenosis.

Malone JB, Bevan PJ, Lewis TJ, Nelson AD, Blaty DE, Kahan ME.

J Orthop. 2017 Nov 6;15(1):36-39. doi: 10.1016/j.jor.2017.11.001. eCollection 2018 Mar.

15.

Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014.

Guan Q, Khuu W, Spithoff S, Kiran T, Kahan M, Tadrous M, Martins D, Leece P, Gomes T.

Drug Alcohol Depend. 2017 Aug 1;177:315-321. doi: 10.1016/j.drugalcdep.2017.05.002. Epub 2017 Jul 19.

PMID:
28733101
16.

Prise en charge des troubles de consommation d’opioïdes en première ligne: Abstinence, méthadone ou buprénorphine-naloxone?

Srivastava A, Kahan M, Nader M.

Can Fam Physician. 2017 Mar;63(3):e153-e159. Review. French.

PMID:
28292811
Free PMC Article
17.

Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?

Srivastava A, Kahan M, Nader M.

Can Fam Physician. 2017 Mar;63(3):200-205. Review.

18.

Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.

Mamakwa S, Kahan M, Kanate D, Kirlew M, Folk D, Cirone S, Rea S, Parsons P, Edwards C, Gordon J, Main F, Kelly L.

Can Fam Physician. 2017 Feb;63(2):137-145.

19.

Work Limitations 4 Years After Mild Traumatic Brain Injury: A Cohort Study.

Theadom A, Barker-Collo S, Jones K, Kahan M, Te Ao B, McPherson K, Starkey N, Feigin V; BIONIC4you Research Group.

Arch Phys Med Rehabil. 2017 Aug;98(8):1560-1566. doi: 10.1016/j.apmr.2017.01.010. Epub 2017 Feb 8.

PMID:
28188778
20.

Accuracy of an International Classification of Diseases Code Surveillance System in the Identification of Traumatic Brain Injury.

Barker-Collo S, Theadom A, Jones K, Feigin VL, Kahan M.

Neuroepidemiology. 2016;47(1):46-52. doi: 10.1159/000448403. Epub 2016 Aug 10.

PMID:
27504965
21.

Optimization of DNA extraction and PCR protocols for phylogenetic analysis in Schinopsis spp. and related Anacardiaceae.

Mogni VY, Kahan MA, de Queiroz LP, Vesprini JL, Ortiz JP, Prado DE.

Springerplus. 2016 Apr 18;5:477. doi: 10.1186/s40064-016-2118-4. eCollection 2016.

22.

A quantitative evaluation of alcohol withdrawal tremors.

Aarabi P, Norouzi N, Dear T, Carver S, Bromberg S, Gray S, Kahan M, Borgundvaag B.

Conf Proc IEEE Eng Med Biol Soc. 2015;2015:6215-8. doi: 10.1109/EMBC.2015.7319812.

PMID:
26737712
23.

Obstetric and Gynecologic Resident Ultrasound Education Project: Is the Current Level of Gynecologic Ultrasound Training in Canada Meeting the Needs of Residents and Faculty?

Green J, Kahan M, Wong S.

J Ultrasound Med. 2015 Sep;34(9):1583-9. doi: 10.7863/ultra.15.14.10067. Epub 2015 Aug 7.

PMID:
26254157
24.

Tamper-resistant drugs cannot solve the opioid crisis.

Leece P, Orkin AM, Kahan M.

CMAJ. 2015 Jul 14;187(10):717-718. doi: 10.1503/cmaj.150329. Epub 2015 Jun 29. No abstract available.

25.
26.
27.

Paradigm shift: Moving the management of alcohol use disorders from specialized care to primary care.

Spithoff S, Kahan M.

Can Fam Physician. 2015 Jun;61(6):491-3, 495-7. English, French. No abstract available.

28.

Predictors of Opioid-Related Death During Methadone Therapy.

Leece P, Cavacuiti C, Macdonald EM, Gomes T, Kahan M, Srivastava A, Steele L, Luo J, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

J Subst Abuse Treat. 2015 Oct;57:30-5. doi: 10.1016/j.jsat.2015.04.008. Epub 2015 Apr 15.

29.

Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a canadian multisite cohort study.

Ordean A, Kahan M, Graves L, Abrahams R, Kim T.

J Obstet Gynaecol Can. 2015 Mar;37(3):252-257. doi: 10.1016/S1701-2163(15)30311-X.

PMID:
26001872
30.

Time-frequency visualization of alcohol withdrawal tremors.

Carver S, Norouzi N, Bromberg S, Gray S, Kahan M, Aarabi P, Borgundvaag B.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:5474-7. doi: 10.1109/EMBC.2014.6944865.

PMID:
25571233
31.

Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations.

Kahan M, Srivastava A, Spithoff S, Bromley L.

Can Fam Physician. 2014 Dec;60(12):1083-90. Review.

32.

Development and Evaluation of the Curriculum for BOLD (Bronx Oncology Living Daily) Healthy Living: a Diabetes Prevention and Control Program for Underserved Cancer Survivors.

Conlon BA, Kahan M, Martinez M, Isaac K, Rossi A, Skyhart R, Wylie-Rosett J, Moadel-Robblee A.

J Cancer Educ. 2015 Sep;30(3):535-45. doi: 10.1007/s13187-014-0750-7.

33.

The management of opioid dependence during pregnancy in rural and remote settings.

Jumah NA, Graves L, Kahan M.

CMAJ. 2015 Jan 6;187(1):E41-E46. doi: 10.1503/cmaj.131723. Epub 2014 Oct 6. Review. No abstract available.

34.

Approach to cannabis use disorder in primary care: focus on youth and other high-risk users.

Turner SD, Spithoff S, Kahan M.

Can Fam Physician. 2014 Sep;60(9):801-8, e423-32. Review. English, French.

35.

Cannabis and Canadian youth: evidence, not ideology.

Spithoff S, Kahan M.

Can Fam Physician. 2014 Sep;60(9):785-7, 793-5. English, French. No abstract available.

36.

Guideline harmonization and implementation plan for the BETTER trial: Building on Existing Tools to Improve Chronic Disease Prevention and Screening in Family Practice.

Campbell-Scherer D, Rogers J, Manca D, Lang-Robertson K, Bell S, Salvalaggio G, Greiver M, Korownyk C, Klein D, Carroll JC, Kahan M, Meuser J, Buchman S, Barrett RM, Grunfeld E.

CMAJ Open. 2014 Jan 22;2(1):E1-E10. doi: 10.9778/cmajo.20130040. eCollection 2014 Jan.

37.

New medical marijuana regulations: the coming storm.

Kahan M, Srivastava A.

CMAJ. 2014 Sep 2;186(12):895-6. doi: 10.1503/cmaj.131821. Epub 2014 Jun 23. No abstract available.

38.

Preventing and managing aberrant drug-related behavior in primary care: systematic review of outcomes evidence.

Argoff CE, Kahan M, Sellers EM.

J Opioid Manag. 2014 Mar-Apr;10(2):119-34. doi: 10.5055/jom.2014.0201. Review.

PMID:
24715667
39.

Sports-related brain injury in the general population: an epidemiological study.

Theadom A, Starkey NJ, Dowell T, Hume PA, Kahan M, McPherson K, Feigin V; BIONIC Research Group.

J Sci Med Sport. 2014 Nov;17(6):591-6. doi: 10.1016/j.jsams.2014.02.001. Epub 2014 Feb 9.

PMID:
24602688
40.

Integrated care for pregnant women on methadone maintenance treatment: Canadian primary care cohort study.

Ordean A, Kahan M, Graves L, Abrahams R, Boyajian T.

Can Fam Physician. 2013 Oct;59(10):e462-9.

41.

Effect of a course-based intervention and effect of medical regulation on physicians' opioid prescribing.

Kahan M, Gomes T, Juurlink DN, Manno M, Wilson L, Mailis-Gagnon A, Srivastava A, Reardon R, Dhalla IA, Mamdani MM.

Can Fam Physician. 2013 May;59(5):e231-9.

42.

Incidence of traumatic brain injury in New Zealand: a population-based study.

Feigin VL, Theadom A, Barker-Collo S, Starkey NJ, McPherson K, Kahan M, Dowell A, Brown P, Parag V, Kydd R, Jones K, Jones A, Ameratunga S; BIONIC Study Group.

Lancet Neurol. 2013 Jan;12(1):53-64. doi: 10.1016/S1474-4422(12)70262-4. Epub 2012 Nov 22.

PMID:
23177532
43.

Computerised tomography indices of raised intracranial pressure and traumatic brain injury severity in a New Zealand sample.

Barker-Collo SL, Starkey N, Kahan M, Theadom A, Feigin V.

N Z Med J. 2012 Aug 24;125(1360):92-4. No abstract available.

PMID:
22932663
44.
45.

The opioid dependent mother and newborn- an update. The 6th Annual Ivey Symposium.

Abrahams R, Chase C, Desmoulin J, Kahan M, Knoppert D, Koren G, Lyons L, Ordean A, Roukema H, Uddin F.

J Popul Ther Clin Pharmacol. 2012;19(1):e73-7. Epub 2012 Mar 7.

PMID:
22408113
46.

Opioids and chronic pain.

Kahan MM.

CMAJ. 2012 Jan 10;184(1):74. doi: 10.1503/cmaj.112-2003. No abstract available.

47.

Pharmacists' experiences with dispensing opioids: provincial survey.

Kahan M, Wilson L, Wenghofer EF, Srivastava A, Resnick A, Janecek E, Sheehan C.

Can Fam Physician. 2011 Nov;57(11):e448-54.

48.
49.

Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations.

Kahan M, Wilson L, Mailis-Gagnon A, Srivastava A; National Opioid Use Guideline Group.

Can Fam Physician. 2011 Nov;57(11):1269-76, e419-28. English, French.

50.

Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population.

Kahan M, Mailis-Gagnon A, Wilson L, Srivastava A; National Opioid Use Guideline Group.

Can Fam Physician. 2011 Nov;57(11):1257-66, e407-18. English, French.

Supplemental Content

Support Center